Regional Scientific Director, Mid-Atlantic Region
Intellia Therapeutics, Inc.
9 hours ago
On-site
Cambridge, MA
$216,000 - $264,000 USD yearly
Medical Affairs
Responsibilities:
- Serve as a customer-facing Regional Scientific Director to establish trusted partnerships in the healthcare community for CRISPR-based gene editing programs (nex-z and lonvo-z).
- Engage KOLs across ATTR amyloidosis and HAE: educate on platform, mechanisms of action, and clinical data; identify patient journey and site capabilities.
- Develop individualized scientific engagement plans aligned to scientific narrative and medical strategy.
- Identify external insights and knowledge gaps via listening and timely CRM reporting.
- Attend medical congresses; staff booths, cover sessions, gather and report insights.
- Support Phase 3 trial site start-up/activation/recruitment with scientific education and operational insights.
- Build and maintain relationships with investigators and study site teams; identify and help resolve barriers to activation/recruitment; escalate site feedback to clinical teams.
- Ensure compliance and scientific integrity (timely training and policy adherence).
Qualifications (About You):
- Doctorate/terminal degree (Pharm.D., Ph.D., M.D., or D.O.)
- 3+ years industry/related experience; extensive clinical trial experience including Phase 3.
- Prior pharmaceutical industry experience as MSL/RSD with strong scientific exchange in a compliance/regulatory environment.
- Excellent communication/presentation, project management, and ability to convey complex science to stakeholders.
- 50–70% travel; manage a geographically assigned territory from home.
Highly preferred:
- Therapeutic knowledge in allergy/immunology/HAE, cardiology/ATTR-CM/-PN, or genetic medicine; new product launch experience.
- Valid driver’s license; strong computer skills (Excel, Word, PowerPoint, Outlook, Zoom).
Compensation:
- Base salary: $216,000–$264,000/yr; plus performance-based annual cash bonus and new-hire equity grant.
Applications:
- Accepted on a rolling basis until the position is filled.
- Serve as a customer-facing Regional Scientific Director to establish trusted partnerships in the healthcare community for CRISPR-based gene editing programs (nex-z and lonvo-z).
- Engage KOLs across ATTR amyloidosis and HAE: educate on platform, mechanisms of action, and clinical data; identify patient journey and site capabilities.
- Develop individualized scientific engagement plans aligned to scientific narrative and medical strategy.
- Identify external insights and knowledge gaps via listening and timely CRM reporting.
- Attend medical congresses; staff booths, cover sessions, gather and report insights.
- Support Phase 3 trial site start-up/activation/recruitment with scientific education and operational insights.
- Build and maintain relationships with investigators and study site teams; identify and help resolve barriers to activation/recruitment; escalate site feedback to clinical teams.
- Ensure compliance and scientific integrity (timely training and policy adherence).
Qualifications (About You):
- Doctorate/terminal degree (Pharm.D., Ph.D., M.D., or D.O.)
- 3+ years industry/related experience; extensive clinical trial experience including Phase 3.
- Prior pharmaceutical industry experience as MSL/RSD with strong scientific exchange in a compliance/regulatory environment.
- Excellent communication/presentation, project management, and ability to convey complex science to stakeholders.
- 50–70% travel; manage a geographically assigned territory from home.
Highly preferred:
- Therapeutic knowledge in allergy/immunology/HAE, cardiology/ATTR-CM/-PN, or genetic medicine; new product launch experience.
- Valid driver’s license; strong computer skills (Excel, Word, PowerPoint, Outlook, Zoom).
Compensation:
- Base salary: $216,000–$264,000/yr; plus performance-based annual cash bonus and new-hire equity grant.
Applications:
- Accepted on a rolling basis until the position is filled.